ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,180Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 313

$2.46M Total Retail Price of All Prescriptions

Rank: 1 out of 313

1,262 Patients Receiving at Least One Drug in Part D
20%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

5% of this provider’s 3,234 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$143 was the average price of a prescription from this provider, compared to $116 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
TRAZODONE HCL 1,704 298 10 1 1
RISPERIDONE 1,122 204 2 2
BENZTROPINE MESYLATE 1,029 102 R 3 3
QUETIAPINE FUMARATE 875 149 4 4
FLUOXETINE HCL 775 163 5 7
OLANZAPINE 697 172 6 11
SERTRALINE HCL 648 161 7 6
DIVALPROEX SODIUM ER 542 56 8 14
CITALOPRAM HBR 539 101 9 5
HYDROXYZINE PAMOATE 517 23 R 10 10 25
ZIPRASIDONE HCL 452 60 11 20
ABILIFY 444 142 12 12
LAMOTRIGINE 433 69 13 9
BUPROPION HCL SR 400 125 14 19
SEROQUEL 388 66 15 18
GABAPENTIN 344 60 16 22
INVEGA SUSTENNA 334 0 17 37
CYMBALTA 325 65 18 10
HALOPERIDOL 283 44 19 23
VENLAFAXINE HCL ER 272 48 20 13
DIVALPROEX SODIUM 267 27 21 26
PAROXETINE HCL 251 16 22 16
LITHIUM CARBONATE 239 29 23 24
INVEGA 231 22 24 43
BUPROPION XL 212 36 25 17
ZOLPIDEM TARTRATE 181 62 26 8
BUSPIRONE HCL 179 17 27 27
ESCITALOPRAM OXALATE 178 39 28 21
MIRTAZAPINE 178 62 28 15
SEROQUEL XR 171 20 30 31
ZYPREXA 170 28 31 44
DOXEPIN HCL 166 32 32 40
TOPIRAMATE 154 0 33 30
NAMENDA 128 109 34 29
HALOPERIDOL DECANOATE 127 13 35 34
GEODON 123 11 36 46
AMITRIPTYLINE HCL 113 26 R 37 35
CLOZAPINE 110 0 38 28
BUPROPION HCL 100 21 39 54
RISPERDAL CONSTA 97 0 40 39
PERPHENAZINE 83 0 41 52
DONEPEZIL HCL 73 59 42 32
CHLORPROMAZINE HCL 72 38 43 68
TRIHEXYPHENIDYL HCL 71 0 R 44 53
VENLAFAXINE HCL 64 0 45 49
LEXAPRO 50 12 46 57
FLUPHENAZINE HCL 50 17 46 58
OXCARBAZEPINE 50 0 46 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.